Meta-analysis of 26 studies (1,963 patients with biopsy-proven MASLD): MASH resolved without fibrosis worsening in 12%, and in 25% with observed weight loss >3%; 17% had ≥1-stage fibrosis improvement. These did not differ by BMI, type 2 diabetes or Hispanic/Latino ethnicity.
Meta-analysisn = 1,963
Jayabalan et al. The Impact of Body Weight Change on Liver Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Across Various Histological Endpoints: A Systematic Review and Meta-Analysis